Side-by-side comparison of AI visibility scores, market position, and capabilities
NEOK Bio emerged from stealth in 2025 with $80M in funding targeting neuroinflammation pathways in Alzheimer's disease and ALS using a novel class of innate immune modulators.
NEOK Bio is targeting neuroinflammation — the chronic activation of brain immune cells (microglia and astrocytes) — as a primary driver of neurodegeneration in Alzheimer's disease, ALS, and Parkinson's disease. The company's small molecule drug candidates modulate the NLRP3 inflammasome and related innate immune pathways in the brain, aiming to reduce the toxic inflammatory environment that kills neurons over time.
NY no-code collaborative database with workflow automation received M&A offer April 2025; YC W20 $1M revenue competing with Airtable and Notion for business operations teams without SQL expertise.
Dataland is a New York-based no-code collaborative data management platform — backed by Y Combinator (W20) with funding from South Park Commons and Switch Ventures — providing business teams with a spreadsheet-like interface for centralizing, structuring, and automating business data workflows without SQL expertise, generating $1 million in revenue in 2024 with a 5-9 person team. Received an M&A offer in April 2025, positioning as a competitive alternative to Airtable and Notion in the growing no-code database market.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.